These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31560491)

  • 1. Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis.
    Lubovich S; Zaragoza S; Rodríguez V; Buendía J; Camargo Vargas B; Alchundia Moreira J; Galanternik L; Ratto P; Teper A
    Arch Argent Pediatr; 2019 Oct; 117(5):e466-e472. PubMed ID: 31560491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
    Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
    Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.
    Arvind B; Medigeshi GR; Kapil A; Xess I; Singh U; Lodha R; Kabra SK
    Indian J Med Res; 2020 Jan; 151(1):65-70. PubMed ID: 32134016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
    Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
    PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis in Austria.
    Frischer T; Eber E; Ellemunter H; Zacharasiewicz A; Kaluza I; Riedler J; Renner S
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):527-532. PubMed ID: 28236043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determinants of survival among adults with cystic fibrosis-a cohort study.
    Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
    J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
    Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.
    Sanders DB; Bittner RC; Rosenfeld M; Hoffman LR; Redding GJ; Goss CH
    Am J Respir Crit Care Med; 2010 Sep; 182(5):627-32. PubMed ID: 20463179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
    Jacques I; Derelle J; Weber M; Vidailhet M
    Eur J Pediatr; 1998 May; 157(5):427-31. PubMed ID: 9625343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.
    Johansen HK; Kovesi TA; Koch C; Corey M; Høiby N; Levison H
    Pediatr Pulmonol; 1998 Aug; 26(2):89-96. PubMed ID: 9727758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary infections in patients with cystic fibrosis.
    Rajan S; Saiman L
    Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.
    Cogen JD; Onchiri F; Emerson J; Gibson RL; Hoffman LR; Nichols DP; Rosenfeld M
    Ann Am Thorac Soc; 2018 Jun; 15(6):702-709. PubMed ID: 29474110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
    Kerem E; Corey M; Gold R; Levison H
    J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.
    Segonds C; Chabanon G; Couetdic G; Michel-Briand Y; Bingen E
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):841-2. PubMed ID: 8950569
    [No Abstract]   [Full Text] [Related]  

  • 20. Overweight and obesity in deltaF508 homozygous cystic fibrosis.
    Kastner-Cole D; Palmer CN; Ogston SA; Mehta A; Mukhopadhyay S
    J Pediatr; 2005 Sep; 147(3):402-4. PubMed ID: 16182686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.